nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—BCHE—peripheral nervous system neoplasm	0.569	1	CbGaD
Triamcinolone—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0605	0.272	CbGbCtD
Triamcinolone—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0465	0.209	CbGbCtD
Triamcinolone—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0457	0.206	CbGbCtD
Triamcinolone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0231	0.104	CbGbCtD
Triamcinolone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0215	0.0966	CbGbCtD
Triamcinolone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00986	0.0443	CbGbCtD
Triamcinolone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00904	0.0406	CbGbCtD
Triamcinolone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00616	0.0277	CbGbCtD
Triamcinolone—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.00016	0.234	CrCbGaD
Triamcinolone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000127	0.187	CrCbGaD
Triamcinolone—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000577	CcSEcCtD
Triamcinolone—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00012	0.000577	CcSEcCtD
Triamcinolone—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00012	0.000575	CcSEcCtD
Triamcinolone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000119	0.000573	CcSEcCtD
Triamcinolone—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000119	0.000573	CcSEcCtD
Triamcinolone—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000119	0.000573	CcSEcCtD
Triamcinolone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000119	0.000571	CcSEcCtD
Triamcinolone—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000571	CcSEcCtD
Triamcinolone—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.00057	CcSEcCtD
Triamcinolone—Back pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.000567	CcSEcCtD
Triamcinolone—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000567	CcSEcCtD
Triamcinolone—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000566	CcSEcCtD
Triamcinolone—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000118	0.000565	CcSEcCtD
Triamcinolone—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000565	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000564	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000559	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000557	CcSEcCtD
Triamcinolone—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000555	CcSEcCtD
Triamcinolone—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000555	CcSEcCtD
Triamcinolone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.000551	CcSEcCtD
Triamcinolone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000547	CcSEcCtD
Triamcinolone—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000546	CcSEcCtD
Triamcinolone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000545	CcSEcCtD
Triamcinolone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000114	0.000545	CcSEcCtD
Triamcinolone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000113	0.000544	CcSEcCtD
Triamcinolone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.00054	CcSEcCtD
Triamcinolone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000112	0.00054	CcSEcCtD
Triamcinolone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000539	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000112	0.000539	CcSEcCtD
Triamcinolone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000538	CcSEcCtD
Triamcinolone—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000538	CcSEcCtD
Triamcinolone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000112	0.000535	CcSEcCtD
Triamcinolone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000112	0.000535	CcSEcCtD
Triamcinolone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000111	0.000535	CcSEcCtD
Triamcinolone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000111	0.000531	CcSEcCtD
Triamcinolone—Malaise—Etoposide—peripheral nervous system neoplasm	0.00011	0.000529	CcSEcCtD
Triamcinolone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000529	CcSEcCtD
Triamcinolone—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000529	CcSEcCtD
Triamcinolone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00011	0.000527	CcSEcCtD
Triamcinolone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000525	CcSEcCtD
Triamcinolone—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000524	CcSEcCtD
Triamcinolone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000109	0.000523	CcSEcCtD
Triamcinolone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000109	0.000523	CcSEcCtD
Triamcinolone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000109	0.000523	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000522	CcSEcCtD
Triamcinolone—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000519	CcSEcCtD
Triamcinolone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000519	CcSEcCtD
Triamcinolone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000108	0.000519	CcSEcCtD
Triamcinolone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000517	CcSEcCtD
Triamcinolone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000107	0.000516	CcSEcCtD
Triamcinolone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000107	0.000515	CcSEcCtD
Triamcinolone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000107	0.000515	CcSEcCtD
Triamcinolone—Rash—Topotecan—peripheral nervous system neoplasm	0.000107	0.000514	CcSEcCtD
Triamcinolone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000107	0.000514	CcSEcCtD
Triamcinolone—Cough—Etoposide—peripheral nervous system neoplasm	0.000107	0.000512	CcSEcCtD
Triamcinolone—Headache—Topotecan—peripheral nervous system neoplasm	0.000107	0.000511	CcSEcCtD
Triamcinolone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000106	0.00051	CcSEcCtD
Triamcinolone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000106	0.00051	CcSEcCtD
Triamcinolone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00051	CcSEcCtD
Triamcinolone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000106	0.00051	CcSEcCtD
Triamcinolone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000106	0.00051	CcSEcCtD
Triamcinolone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000106	0.00051	CcSEcCtD
Triamcinolone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000106	0.000508	CcSEcCtD
Triamcinolone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000106	0.000508	CcSEcCtD
Triamcinolone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000106	0.000507	CcSEcCtD
Triamcinolone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000106	0.000507	CcSEcCtD
Triamcinolone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000106	0.000507	CcSEcCtD
Triamcinolone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000105	0.000505	CcSEcCtD
Triamcinolone—Pain—Vincristine—peripheral nervous system neoplasm	0.000105	0.000505	CcSEcCtD
Triamcinolone—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000505	CcSEcCtD
Triamcinolone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000505	CcSEcCtD
Triamcinolone—Rash—Melphalan—peripheral nervous system neoplasm	0.000105	0.000504	CcSEcCtD
Triamcinolone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000105	0.000503	CcSEcCtD
Triamcinolone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000497	CcSEcCtD
Triamcinolone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000103	0.000493	CcSEcCtD
Triamcinolone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.000487	CcSEcCtD
Triamcinolone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000487	CcSEcCtD
Triamcinolone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000485	CcSEcCtD
Triamcinolone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000101	0.000485	CcSEcCtD
Triamcinolone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000482	CcSEcCtD
Triamcinolone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0001	0.000481	CcSEcCtD
Triamcinolone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0001	0.000481	CcSEcCtD
Triamcinolone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00048	CcSEcCtD
Triamcinolone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	9.98e-05	0.000479	CcSEcCtD
Triamcinolone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000479	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	9.92e-05	0.000476	CcSEcCtD
Triamcinolone—Infection—Etoposide—peripheral nervous system neoplasm	9.91e-05	0.000476	CcSEcCtD
Triamcinolone—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	9.9e-05	0.000475	CcSEcCtD
Triamcinolone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	9.89e-05	0.000475	CcSEcCtD
Triamcinolone—Nausea—Melphalan—peripheral nervous system neoplasm	9.89e-05	0.000475	CcSEcCtD
Triamcinolone—Asthma—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000472	CcSEcCtD
Triamcinolone—Influenza—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000472	CcSEcCtD
Triamcinolone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.78e-05	0.000469	CcSEcCtD
Triamcinolone—Tachycardia—Etoposide—peripheral nervous system neoplasm	9.74e-05	0.000467	CcSEcCtD
Triamcinolone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.74e-05	0.000467	CcSEcCtD
Triamcinolone—Prednisone—ABCB1—peripheral nervous system neoplasm	9.73e-05	0.143	CrCbGaD
Triamcinolone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	9.71e-05	0.000466	CcSEcCtD
Triamcinolone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	9.65e-05	0.000463	CcSEcCtD
Triamcinolone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.000463	CcSEcCtD
Triamcinolone—Bronchitis—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.000454	CcSEcCtD
Triamcinolone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	9.42e-05	0.000452	CcSEcCtD
Triamcinolone—Pain—Cisplatin—peripheral nervous system neoplasm	9.31e-05	0.000447	CcSEcCtD
Triamcinolone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000446	CcSEcCtD
Triamcinolone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.17e-05	0.00044	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.00044	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000439	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000437	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000437	CcSEcCtD
Triamcinolone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.07e-05	0.000435	CcSEcCtD
Triamcinolone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.04e-05	0.000434	CcSEcCtD
Triamcinolone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.97e-05	0.000431	CcSEcCtD
Triamcinolone—Prednisolone—ABCB1—peripheral nervous system neoplasm	8.97e-05	0.132	CrCbGaD
Triamcinolone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.96e-05	0.00043	CcSEcCtD
Triamcinolone—Weight increased—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.00043	CcSEcCtD
Triamcinolone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000428	CcSEcCtD
Triamcinolone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.9e-05	0.000427	CcSEcCtD
Triamcinolone—Asthenia—Vincristine—peripheral nervous system neoplasm	8.84e-05	0.000424	CcSEcCtD
Triamcinolone—Betamethasone—ABCB1—peripheral nervous system neoplasm	8.78e-05	0.129	CrCbGaD
Triamcinolone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.77e-05	0.000421	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.00042	CcSEcCtD
Triamcinolone—Rash—Dactinomycin—peripheral nervous system neoplasm	8.69e-05	0.000417	CcSEcCtD
Triamcinolone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.61e-05	0.000413	CcSEcCtD
Triamcinolone—Fatigue—Etoposide—peripheral nervous system neoplasm	8.6e-05	0.000413	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.6e-05	0.000413	CcSEcCtD
Triamcinolone—Pain—Etoposide—peripheral nervous system neoplasm	8.53e-05	0.000409	CcSEcCtD
Triamcinolone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000409	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	0.000406	CcSEcCtD
Triamcinolone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.45e-05	0.000406	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000397	CcSEcCtD
Triamcinolone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000397	CcSEcCtD
Triamcinolone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.22e-05	0.000395	CcSEcCtD
Triamcinolone—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.19e-05	0.000393	CcSEcCtD
Triamcinolone—Dizziness—Vincristine—peripheral nervous system neoplasm	8.15e-05	0.000391	CcSEcCtD
Triamcinolone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.13e-05	0.00039	CcSEcCtD
Triamcinolone—Rash—Alitretinoin—peripheral nervous system neoplasm	8.06e-05	0.000387	CcSEcCtD
Triamcinolone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.05e-05	0.000386	CcSEcCtD
Triamcinolone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.02e-05	0.000385	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000385	CcSEcCtD
Triamcinolone—Headache—Alitretinoin—peripheral nervous system neoplasm	8.01e-05	0.000384	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000382	CcSEcCtD
Triamcinolone—Urticaria—Etoposide—peripheral nervous system neoplasm	7.93e-05	0.00038	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.00038	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000379	CcSEcCtD
Triamcinolone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.89e-05	0.000379	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000378	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000378	CcSEcCtD
Triamcinolone—Vomiting—Vincristine—peripheral nervous system neoplasm	7.83e-05	0.000376	CcSEcCtD
Triamcinolone—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.81e-05	0.000375	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000375	CcSEcCtD
Triamcinolone—Rash—Vincristine—peripheral nervous system neoplasm	7.77e-05	0.000373	CcSEcCtD
Triamcinolone—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.76e-05	0.000372	CcSEcCtD
Triamcinolone—Headache—Vincristine—peripheral nervous system neoplasm	7.72e-05	0.00037	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000367	CcSEcCtD
Triamcinolone—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.59e-05	0.000364	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	7.42e-05	0.000356	CcSEcCtD
Triamcinolone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.35e-05	0.000353	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000351	CcSEcCtD
Triamcinolone—Nausea—Vincristine—peripheral nervous system neoplasm	7.32e-05	0.000351	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.00035	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.00035	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000347	CcSEcCtD
Triamcinolone—Asthenia—Etoposide—peripheral nervous system neoplasm	7.16e-05	0.000344	CcSEcCtD
Triamcinolone—Pruritus—Etoposide—peripheral nervous system neoplasm	7.06e-05	0.000339	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000337	CcSEcCtD
Triamcinolone—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.92e-05	0.000332	CcSEcCtD
Triamcinolone—Rash—Cisplatin—peripheral nervous system neoplasm	6.87e-05	0.00033	CcSEcCtD
Triamcinolone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.86e-05	0.000329	CcSEcCtD
Triamcinolone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	6.86e-05	0.101	CrCbGaD
Triamcinolone—Erythema—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000329	CcSEcCtD
Triamcinolone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000322	CcSEcCtD
Triamcinolone—Back pain—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000318	CcSEcCtD
Triamcinolone—Dizziness—Etoposide—peripheral nervous system neoplasm	6.6e-05	0.000317	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000312	CcSEcCtD
Triamcinolone—Nausea—Cisplatin—peripheral nervous system neoplasm	6.47e-05	0.00031	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000305	CcSEcCtD
Triamcinolone—Vomiting—Etoposide—peripheral nervous system neoplasm	6.34e-05	0.000304	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000304	CcSEcCtD
Triamcinolone—Rash—Etoposide—peripheral nervous system neoplasm	6.29e-05	0.000302	CcSEcCtD
Triamcinolone—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.29e-05	0.000302	CcSEcCtD
Triamcinolone—Headache—Etoposide—peripheral nervous system neoplasm	6.25e-05	0.0003	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000298	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000297	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000295	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000295	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000294	CcSEcCtD
Triamcinolone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.02e-05	0.000289	CcSEcCtD
Triamcinolone—Cough—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000287	CcSEcCtD
Triamcinolone—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000285	CcSEcCtD
Triamcinolone—Nausea—Etoposide—peripheral nervous system neoplasm	5.93e-05	0.000284	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000284	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000282	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.00028	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.76e-05	0.000277	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000274	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000274	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000273	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000273	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000268	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000268	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000267	CcSEcCtD
Triamcinolone—Infection—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.000267	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000266	CcSEcCtD
Triamcinolone—Shock—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000264	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000264	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000263	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000262	CcSEcCtD
Triamcinolone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000259	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000259	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.33e-05	0.000256	CcSEcCtD
Triamcinolone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000253	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000248	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000248	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000247	CcSEcCtD
Triamcinolone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	5.11e-05	0.075	CrCbGaD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000245	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000244	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000243	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000242	CcSEcCtD
Triamcinolone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000241	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.00024	CcSEcCtD
Triamcinolone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000239	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.000236	CcSEcCtD
Triamcinolone—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000231	CcSEcCtD
Triamcinolone—Pain—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.00023	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000226	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000225	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000223	CcSEcCtD
Triamcinolone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000221	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000221	CcSEcCtD
Triamcinolone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000219	CcSEcCtD
Triamcinolone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000214	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000213	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000212	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.42e-05	0.000212	CcSEcCtD
Triamcinolone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000205	CcSEcCtD
Triamcinolone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000198	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000197	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.000196	CcSEcCtD
Triamcinolone—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000193	CcSEcCtD
Triamcinolone—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.00019	CcSEcCtD
Triamcinolone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000183	CcSEcCtD
Triamcinolone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000178	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000177	CcSEcCtD
Triamcinolone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000176	CcSEcCtD
Triamcinolone—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000171	CcSEcCtD
Triamcinolone—Rash—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000169	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.000169	CcSEcCtD
Triamcinolone—Headache—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000168	CcSEcCtD
Triamcinolone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000164	CcSEcCtD
Triamcinolone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000159	CcSEcCtD
Triamcinolone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000158	CcSEcCtD
Triamcinolone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000157	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000156	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000156	CcSEcCtD
Triamcinolone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000148	CcSEcCtD
